-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $269

Benzinga·12/12/2025 17:00:46
語音播報
Morgan Stanley analyst Terence Flynn maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $261 to $269.